# GSK (GSK) — Overview

GSK · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/gsk

## Price

Last close $49.02 on Oct 15, 2026. 52-week range $43.24 – $61.18.

## Company profile

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $43.9B |
| Revenue (quarter) | $11.1B |
| Revenue growth (year over year) | 1.74% |
| Gross profit (trailing twelve months) | $31.9B |
| Gross margin | 72.71% |
| Net income (trailing twelve months) | $6.9B |
| Net income (quarter) | $733.2M |
| Net income growth (year over year) | -67.54% |
| Net margin | 15.80% |
| Return on equity | 29.10% |
| EPS (trailing twelve months) | $3.16 |
| Book value per share | $11.57 |
| P/E (trailing twelve months) | 15.6 |
| Price to book | 4.4 |
| Debt to assets | 72.18% |
| Payout ratio | 44.42% |
| Dividend yield | 3.65% |

## Frequently Asked Questions

### Is GSK (GSK) profitable?

Yes. GSK earned $6.9B in net income over the trailing twelve months, a net margin of 15.80%.

### How much revenue does GSK (GSK) make?

GSK generated $43.9B in revenue over the trailing twelve months, up 1.74% year over year.

### What is GSK's P/E ratio?

GSK trades at 15.6 times trailing twelve-month earnings, on an EPS of $3.16.

### How do I buy stock in GSK (GSK)?

GSK trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).
